Evidence map›Paper›PMID 34287342›Full record

ArticlePharmacy (Basel, Switzerland)2021

Effectiveness and Feasibility of Pharmacist-Driven Penicillin Allergy De-Labeling Pilot Program without Skin Testing or Oral Challenges.

You-Chan Song, Zachary J Nelson, Michael A Wankum, Krista D Gens

Open access · goldAbstract read
In one paragraph

Article in Pharmacy (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 3 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 3 syntheses or guidelines pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. The effectiveness of interventions that support penicillin allergy assessment and delabeling of adult and pediatric patients by nonallergy specialists: a systematic review and meta-analysis.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2023
    Pooled it
  4. Implementation of a Pharmacist-Led Penicillin Allergy Interview at a Veterans Care Facility.Federal practitioner : for the health care professionals of the VA, DoD, and PHS · 2026
    Article
  5. Article
  6. Article
  7. How to Define and Manage Low-Risk Drug Allergy Labels.The journal of allergy and clinical immunology. In practice · 2024
    Review
  8. Review
  9. A new pathway for penicillin delabeling in Norway.The World Allergy Organization journal · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

You-Chan SongDepartment of Pharmacy, Abbott Northwestern Hospital, Mail Route 11321, 800 East 28th Street, Minneapolis, MN 55407, USA.ORCID 0000-0002-5622-9424
Zachary J NelsonDepartment of Pharmacy, Abbott Northwestern Hospital, Mail Route 11321, 800 East 28th Street, Minneapolis, MN 55407, USA.ORCID 0000-0002-2759-801X
Michael A WankumDepartment of Pharmacy, Abbott Northwestern Hospital, Mail Route 11321, 800 East 28th Street, Minneapolis, MN 55407, USA.
Krista D GensDepartment of Pharmacy, Abbott Northwestern Hospital, Mail Route 11321, 800 East 28th Street, Minneapolis, MN 55407, USA.
Abbott Northwestern Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Documented penicillin allergies have been associated with an increased risk of adverse outcomes. The goal of this project was to assess the effectiveness and feasibility of a pharmacist-led penicillin allergy "de-labeling" process that does not involve labor-intensive skin testing or direct oral challenges. Adult patients with penicillin allergies were identified and interviewed by an infectious diseases pharmacy resident during a 3-month pilot period. Using an evidence-based standardized checklist, the pharmacist determined if an allergy qualified for de-labeling. In total, 66 patients were interviewed during the pilot period. The average time spent was 5.2 min per patient interviewed. Twelve patients (18%) met the criteria for de-labeling and consented to the removal of the allergy. Four patients (6%) met the criteria but declined removal of the allergy. In brief, 58.3% of patients (7/12) who were de-labeled and 50% of patients (2/4) who declined de-labeling but had their allergy updated to reflect intolerance were subsequently prescribed beta-lactam antibiotics and all (9/9, 100%) were able to tolerate these agents. A pharmacist-led penicillin allergy de-labeling process utilizing a standardized checklist is an effective and feasible method for removing penicillin allergies in patients without a true allergy.

Indexed as

allergyAntimicrobial Stewardshiphypersensitivitypenicillinspharmacistspharmacy services

Identifiers

PMID34287342
PMCPMC8293328
OpenAlexW3185169724

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.